| [1] |
Khan KS, Wojdyla D, Say L，et al. WHO analysis of causes of maternal death: a systematic review[J]．Lancet，2006，367(9516)：1066–1074.
|
| [2] |
Vikse BE，Irgens LM，Leivestad T，et al.Preeclampsia and the risk of end-stage renal disease[J]．N Engl J Med，2008，359(8)：800–809.
|
| [3] |
Matthys LA，Coppage KH，Lambers DS，et al.Delayed postpartum preeclampsia：an experience of 151 cases[J]．Am J Obstet Gynecol，2004，190(5)：1464–1466.
|
| [4] |
Schutte JM，Schuitemaker NW，van Roosmalen J，et al.Dutch Maternal Mortality Committee.Substandard care in maternal mortality due to hypertensive disease in pregnancy in the Netherlands[J]．BJOG，2008，115(6)：732–736.
|
| [5] |
Levine RJ，Lam C，Qian C，et al.Soluble endoglin and other circulating antiangiogenic factors in preeclampsia[J]．N Engl J Med，2006，355(10)：992–1005.
|
| [6] |
Moore-Simas TA，Crawford SL，Solitro MJ，et al.Angiogenic factors for the prediction of preeclampsia in high-risk women[J]．Am J Obstet Gynecol, 2007，197(3)：241–248.
|
| [7] |
Vatten LJ，Eskild A，Nilsen TI，et al.Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia[J]. Am J Obstet Gynecol，2007，196(3)：e231–e236.
|
| [8] |
Noori M，Donald AE，Angelakopoulou A，et al. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension [J]．Circulation, 2010，122(5)：478–487.
|
| [9] |
De Vivo A，Baviera G，Giordano D，et al.Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia[J]．Acta Obstet Gynecol Scand，2008，87(8)：837–842.
|
| [10] |
高劲松，沈晶，蒋宇林，等．妊娠中期孕妇血清sFlt-1，PlGF水平及比值变化预测子痫前期发生的价值[J]．中华妇产科学杂志，2014，49(1)：22–25.
|
| [11] |
Sunderji S，Gaziano E，Wothe D，et al.Automated assays for sVEGF R1 and PIGF as an aid in the diagnosis of preterm preeclampsia: a prospective clinical study[J]．Am J Obstet Gynecol，2010，202(1)：e41–e47.
|
| [12] |
Rana S，Karumanchi SA，Levine RJ，et al.Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia[J]. Hypertension，2007，50(1)：137–142.
|
| [13] |
Levine RJ，Thadhani R，Qian C，et al.Urinary placental growth factor and risk of preeclampsia[J]．JAMA，2005，293(1)：77–85.
|
| [14] |
Aggarwal PK，Jain V，Sakhuja V，et al.Low urinary placental growth factor is a marker of pre-eclampsia[J]．Kidney Int，2006，69(3)：621–624.
|
| [15] |
Perni U，Sison C，Sharma V，et al.Angiogenic factors in superimposed preeclampsia: a longitudinal study of women with chronic hypertension during pregnancy[J]. Hypertension，2012，59(3)：740–746.
|
| [16] |
Masuyama H，Nobumoto E，Okimoto N，et al.Superimposed preeclampsia in women with chronic kidney disease[J]．Gynecol Obstet Invest，2012，74(4)：274–281.
|
| [17] |
Stamatopoulou A，Cowans NJ，Matwejew E，et al.Placental protein-13 and pregnancy-associated plasma protein-A as first trimester screening markers for hypertensive disorders and small for gestational age outcomes[J]．Hypertens Pregnancy，2011，30(4)：384–395.
|
| [18] |
Akolekar R，Syngelaki A，Beta J，et al.Maternal serum placental protein 13 at 11-13 weeks of gestation in preeclampsia[J]．Prenatal Diagn, 2009，29(12)：1103–1108.
|
| [19] |
Steel SA，Pearce JM，Chamberlain G．Doppler ultrasound of the uteroplacental circulation as a screening test for severe pre-eclampsia with intra-uterine growth retardation[J]．Eur J Obstet Gynecol Reprod Biol，1988，28(4)：279–287.
|
| [20] |
Aardema MW，De Wolf BT，Saro MC，et al. Quantification of the diastolic notch in Doppler ultrasound screening of uterine arteries[J]．Ultrasound Obstet Gynecol，2000，16(7)：630–634.
|
| [21] |
Espinoza J，Romero R，Nien JK，et al.Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor[J]．Am J Obstet Gynecol，2007，196(4)：326–326.
|
| [22] |
Cnossen JS，Morris RK，ter Riet G，et al.Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis[J]．CMAJ，2008，178(6)：701–711.
|
| [23] |
Barton JR，Sibai BM.Prediction and prevention of recurrent preeclampsia[J]．Obstet Gynecol，2008，112(2 Pt 1)：359–372.
|
| [24] |
Poon LC, Kametas NA, Maiz N，et al. Firsttrimester prediction of hypertensive disorders in pregnancy[J]．Hypertension，2009，53(5)：812–818.
|
| [25] |
Eremina V，Sood M，Haigh J，et al.Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases[J]. J Clin Invest，2003，111(5)：707–716.
|
| [26] |
Garovic VD, Wagner SJ, Petrovic LM, et al. Glomerular expression of nephrin and synaptopodin, but not podocin, is decreased in kidney sections from women with preeclampsia[J]. Nephrol Dial Transpl，2007，22(4)：1136–1143.
|
| [27] |
Collino F, Bussolati B, Gerbaudo E, et al. Preeclamptic sera induce nephrin shedding from podocytes through endothelin-1 release by endothelial glomerular cells[J]. Am J Physiol Renal Physiol，2008，294(5)：F1185–F1194.
|
| [28] |
Aita K，Etoh M，Hamada H，et al.Acute and transient podocyte loss and proteinuria in preeclampsia[J]．Nephron Clin Pract，2009，112(2)：65–70.
|
| [29] |
Jim B，Jean-Louis P，Qipo A，et al.Podocyturia as a diagnosticmarker for preeclampsia amongst high-risk pregnant patients[J]．J Pregnancy, 2012，2012：984630.
|
| [30] |
Wang Y，Zhao S，Loyd S，et al.Increased urinary excretion of nephrin, podocalyxin, and betaig-h3 in women with preeclampsia[J]．Am J Physiol Ren Physiol，2012，302(9)：F1084–F1089.
|
| [31] |
Greene CS，Troyanskaya OG.Integrative systems biology for datadriven knowledge discovery[J]．Semin Nephrol，2010，30(5)：443–454.
|
| [32] |
Barratt J，Topham P．Urine proteomics: the present and future of measuring urinary protein components in disease[J]．CMAJ，2007，177(4)：361–368.
|
| [33] |
Buhimschi IA，Zhao G，Funai EF，et al.Proteomic profiling of urine identifies specific fragments of SERPINA1 and albumin as biomarkers of preeclampsia[J]．Am J Obstet Gynecol，2008，199(5)：551–551.
|
| [34] |
Bergman D，Kadner SS，Cruz MR，et al.Synthesis of alpha 1-antichymotrypsin and alpha 1-antitrypsin by human trophoblast[J]．Pediatr Res，1993，34(3)：312–317.
|
| [35] |
Engstrom G，Janzon L，Berglund G，et al.Blood pressure increase and incidence of hypertension in relation to inflammation-sensitive plasma proteins[J]．Arterioscler Thromb Vasc Biol，2002，22(12)：2054–2058.
|
| [36] |
Chen G，Zhang Y，Jin X，et al.Urinary proteomics analysis for renal injury in hypertensive disorders of pregnancy with iTRAQ labeling and LC-MS/MS[J]．Proteomics Clin Appl，2011，5(5-6)：300–310.
|
| [37] |
Carty DM，Siwy J，Brennand JE，et al.Urinary proteomics for prediction of preeclampsia[J]．Hypertension，2011，57(3)：561–569.
|
| [38] |
Kottgen A，Glazer NL，Dehghan A，et al.Multiple loci associated with indices of renal function and chronic kidney disease[J]．NatGenet，2009，41(6)：712–717.
|
| [39] |
Wishart DS，Knox C，Guo AC，et al.HMDB：a knowledgebase for the human metabolome[J]．Nucleic Acids Res，2009，37：603–610.
|
| [40] |
Odibo AO，Goetzinger KR，Odibo L，et al.First-trimester prediction of preeclampsia using metabolomic biomarkers：a discovery phase study[J]．Prenatal Diagn，2011，31(10)：990–994.
|
| [41] |
Bahado-Singh RO，Akolekar R，Mandal R，et al.Metabolomics and first-trimester prediction of early-onset preeclampsia[J]．J Matern Fetal Neonatal Med，2012，25(10)：1840–1847.
|